| Q36554195 | A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). |
| Q37834640 | A contemporary review of stereotactic radiotherapy: inherent dosimetric complexities and the potential for detriment |
| Q37687473 | A dosimetric and treatment efficiency evaluation of stereotactic body radiation therapy for peripheral lung cancer using flattening filter free beams |
| Q48709402 | A further investigation of the centroid-to-centroid method for stereotactic lung radiotherapy: a phantom study |
| Q57282826 | A matched-pair analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer versus early stage non-small cell lung cancer |
| Q83366949 | A method for improved verification of entire IMRT plans by film dosimetry |
| Q49034977 | A patient alignment solution for lung SBRT setups based on a deformable registration technique |
| Q33664774 | A pilot trial of serial 18F-fluorodeoxyglucose positron emission tomography in patients with medically inoperable stage I non-small-cell lung cancer treated with hypofractionated stereotactic body radiotherapy |
| Q37552170 | A propensity-matched analysis of surgery and stereotactic body radiotherapy for early stage non-small cell lung cancer in the elderly |
| Q41789184 | A randomised comparison of three different immobilisation devices for thoracic and abdominal cancers. |
| Q38790915 | A systematic review of outcomes following stereotactic ablative radiotherapy in the treatment of early-stage primary lung cancer |
| Q57498590 | Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up |
| Q46271933 | Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing |
| Q40402791 | Adenovirus-mediated Foxp3 expression in lung epithelial cells ameliorates acute radiation-induced pneumonitis in mice. |
| Q40287365 | Aggravation of dyspnea in stage I non-small cell lung cancer patients following stereotactic body radiotherapy: Is there a dose-volume dependency? |
| Q34337294 | American College of Surgeons Oncology Group Z4099/Radiation Therapy Oncology Group 1021: a randomized study of sublobar resection compared with stereotactic body radiotherapy for high-risk stage I non-small cell lung cancer |
| Q64269417 | Anemia is a poor prognostic factor for stage I non-small cell lung cancer (NSCLC) patients treated with Stereotactic Body Radiation Therapy (SBRT) |
| Q36499983 | Approach to dose definition to the gross tumor volume for lung cancer with respiratory tumor motion |
| Q37657305 | Assessing Survival and Grading the Severity of Complications in Octogenarians Undergoing Pulmonary Lobectomy. |
| Q90105657 | Assessment of biological dosimetric margin for stereotactic body radiation therapy |
| Q36258261 | Beam's-eye-view imaging during non-coplanar lung SBRT. |
| Q64922396 | Choice of immobilization of stereotactic body radiotherapy in lung tumor patient by BMI. |
| Q64325948 | Clinical Outcomes of Stereotactic Body Radiotherapy for Patients With Stage I Small-Cell Lung Cancer: Analysis of a Subset of the Japanese Radiological Society Multi-Institutional SBRT Study Group Database |
| Q38178429 | Clinical introduction of Monte Carlo treatment planning for lung stereotactic body radiotherapy |
| Q36241457 | Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer |
| Q30570350 | Clinical outcome of hypofractionated breath-hold image-guided SABR of primary lung tumors and lung metastases. |
| Q36481633 | Clinical outcome of stereotactic body radiotherapy for primary and oligometastatic lung tumors: a single institutional study with almost uniform dose with different five treatment schedules |
| Q53807656 | Clinical outcome of stereotactic body radiotherapy of 54 Gy in nine fractions for patients with localized lung tumor using a custom-made immobilization system. |
| Q47103518 | Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases |
| Q49356303 | Clinical outcomes following image-guided stereotactic body radiation for pulmonary oligometastases |
| Q30834087 | Clinical outcomes of stage I and IIA non-small cell lung cancer patients treated with stereotactic body radiotherapy using a real-time tumor-tracking radiotherapy system |
| Q34202715 | Clinical outcomes of stereotactic body radiotherapy for stage I non-small cell lung cancer using different doses depending on tumor size |
| Q41559497 | Clinical results of accelerated hypofractionated radiotherapy for central-type small lung tumours |
| Q49286208 | Clinical results of proton beam therapy for elderly patients with non-small cell lung cancer |
| Q36500026 | Clinical results of stereotactic body radiotherapy for Stage I small-cell lung cancer: a single institutional experience |
| Q59048840 | Comparative Study of Superselective Intra-Arterial Chemoradiotherapy versus Radical Surgery on Distant Metastasis for Advanced Oral Cancer |
| Q36343856 | Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours |
| Q38914996 | Comparison of the Effectiveness of Radiofrequency Ablation With Stereotactic Body Radiation Therapy in Inoperable Stage I Non-Small Cell Lung Cancer: A Systemic Review and Pooled Analysis. |
| Q38240581 | Comparison of therapeutic results from radiofrequency ablation and stereotactic body radiotherapy in solitary lung tumors measuring 5 cm or smaller |
| Q83660718 | Comparisons of dose-volume histograms for proton-beam versus 3-D conformal x-ray therapy in patients with stage I non-small cell lung cancer |
| Q26995851 | Complications from Stereotactic Body Radiotherapy for Lung Cancer |
| Q42116312 | Cone-beam computed tomography in lung stereotactic ablative radiation therapy: predictive parameters of early response |
| Q36767669 | Current status of stereotactic body radiotherapy for lung cancer |
| Q34331400 | CyberKnife for hilar lung tumors: report of clinical response and toxicity |
| Q37004652 | CyberKnife robotic radiosurgery system for tumor treatment |
| Q37468265 | Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer |
| Q35796322 | Definitive Treatment of Early-Stage Non-Small Cell Lung Cancer with Stereotactic Ablative Body Radiotherapy in a Community Cancer Center Setting |
| Q33582628 | Design, development of water tank-type lung phantom and dosimetric verification in institutions participating in a phase I study of stereotactic body radiation therapy in patients with T2N0M0 non-small cell lung cancer: Japan Clinical Oncology [...] |
| Q99545499 | Determination of reproducibility of end-exhaled breath-holding in stereotactic body radiation therapy |
| Q37876669 | Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy |
| Q54974398 | Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy. |
| Q84791240 | Dose–Volume Comparison of Proton Radiotherapy and Stereotactic Body Radiotherapy for Non-Small-Cell Lung Cancer |
| Q36279626 | Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer |
| Q39774605 | Dosimetric analysis of imaging changes following pulmonary stereotactic body radiation therapy |
| Q40019138 | Dosimetric and motion analysis of margin-intensive therapy by stereotactic ablative radiotherapy for resectable pancreatic cancer |
| Q42321832 | Dosimetric evaluation of the impacts of different heterogeneity correction algorithms on target doses in stereotactic body radiation therapy for lung tumors |
| Q41890284 | Dosimetric impact of different CT datasets for stereotactic treatment planning using 3D conformal radiotherapy or volumetric modulated arc therapy |
| Q43455935 | Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy |
| Q37789035 | Early detection and screening of lung cancer |
| Q64969902 | Early stage lung cancer survival after wedge resection and stereotactic body radiation. |
| Q47826009 | Effects of collimator angle, couch angle, and starting phase on motion-tracking dynamic conformal arc therapy (4D DCAT). |
| Q47752700 | Efficacy and safety of stereotactic body radiotherapy using CyberKnife in Stage I primary lung tumor |
| Q41241692 | Elucidation of radiation-resistant clones by a serial study of intratumor heterogeneity before and after stereotactic radiotherapy in lung cancer |
| Q27015651 | Emergence of stereotactic body radiation therapy and its impact on current and future clinical practice |
| Q61809528 | Enhanced phosphatidylserine-selective cancer therapy with irradiation and SapC-DOPS nanovesicles |
| Q48604650 | Evaluation of initial setup errors of two immobilization devices for lung stereotactic body radiation therapy (SBRT). |
| Q53459469 | Evaluation of mass-like consolidation after stereotactic body radiation therapy for lung tumors. |
| Q89539024 | Evaluation of the target dose coverage of stereotactic body radiotherapy for lung cancer using helical tomotherapy: A dynamic phantom study |
| Q34076575 | Evaluation of tumor motion effects on dose distribution for hypofractionated intensity-modulated radiotherapy of non-small-cell lung cancer. |
| Q55223198 | Evaluation of tumor motion effects on dose distribution for hypofractionated intensity‐modulated radiotherapy of non‐small‐cell lung cancer. |
| Q83749144 | Factors affecting the local control of stereotactic body radiotherapy for lung tumors including primary lung cancer and metastatic lung tumors |
| Q57058757 | Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702) |
| Q43833349 | Flattening filter-free linac improves treatment delivery efficiency in stereotactic body radiation therapy |
| Q53391674 | Geometrical differences in target volumes between slow CT and 4D CT imaging in stereotactic body radiotherapy for lung tumors in the upper and middle lobe. |
| Q59150093 | Gross tumour volume variations in primary non-small-cell lung cancer during the course of treatment with stereotactic body radiation therapy |
| Q48129987 | Helical tomotherapy for solitary lung tumor: feasibility study and dosimetric evaluation of treatment plans |
| Q41678140 | High Dose Hypofractionated Proton Beam Therapy is a Safe and Feasible Treatment for Central Lung Cancer |
| Q83182085 | High-dose proton therapy and carbon-ion therapy for stage I nonsmall cell lung cancer |
| Q37601085 | Hypofractionated 3D radiotherapy for inoperable T1-3 N0-1 non-small-cell lung cancer |
| Q33729123 | Hypofractionated radiotherapy for lung tumors with online cone beam CT guidance and active breathing control |
| Q37092017 | Hypofractionation in radiation therapy and its impact |
| Q41877200 | Image-guided stereotactic body radiation therapy (SBRT): an emerging treatment paradigm with a new promise in radiation oncology |
| Q35663626 | Imaging characteristics of local recurrences after stereotactic body radiation therapy for stage I non-small cell lung cancer: Evaluation of mass-like fibrosis |
| Q37301068 | Impact of pretreatment whole-tumor perfusion computed tomography and 18F-fluorodeoxyglucose positron emission tomography/computed tomography measurements on local control of non-small cell lung cancer treated with stereotactic body radiotherapy |
| Q42585121 | Implications of a high-definition multileaf collimator (HD-MLC) on treatment planning techniques for stereotactic body radiation therapy (SBRT): a planning study |
| Q34002179 | Improving radiation conformality in the treatment of non-small cell lung cancer |
| Q49356566 | Incidence of rib fractures after stereotactic body radiotherapy for peripheral lung lesions: clinical experience and dose response estimation |
| Q41328822 | Incidence, risk factors, and dose-volume relationship of radiation-induced rib fracture after carbon ion radiotherapy for lung cancer |
| Q35245587 | Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors |
| Q38245739 | Influence of segment width on plan quality for volumetric modulated arc based stereotactic body radiotherapy |
| Q47098978 | Initial clinical experience with stereotactic lung radiotherapy, based on a biological model-driven prescription method |
| Q34717651 | Innovations in image-guided radiotherapy. |
| Q36473560 | Integral dose and radiation-induced secondary malignancies: comparison between stereotactic body radiation therapy and three-dimensional conformal radiotherapy |
| Q36621168 | Intensity-modulated stereotactic body radiotherapy for stage I non-small cell lung cancer |
| Q47827484 | Interobserver variability of patient positioning using four different CT datasets for image registration in lung stereotactic body radiotherapy. |
| Q37006962 | Intrafractional setup errors in patients undergoing non-invasive fixation using an immobilization system during hypofractionated stereotactic radiotherapy for lung tumors |
| Q38051243 | Is radiofrequency ablation or stereotactic ablative radiotherapy the best treatment for radically treatable primary lung cancer unfit for surgery? |
| Q41856048 | Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy |
| Q38705115 | Limitations of PET/CT in the Detection of Occult N1 Metastasis in Clinical Stage I(T1-2aN0) Non-Small Cell Lung Cancer for Staging Prior to Stereotactic Body Radiotherapy |
| Q64997326 | Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age. |
| Q93111716 | Long term outcome after 48 Gy stereotactic ablative body radiotherapy for peripheral stage I non-small cell lung cancer |
| Q44130820 | Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience. |
| Q47149089 | Low and medium doses of hypofractionated stereotactic radiotherapy could be suboptimal for early-stage lung cancer |
| Q47102090 | Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomes |
| Q36235727 | LungTech, an EORTC Phase II trial of stereotactic body radiotherapy for centrally located lung tumours: a clinical perspective |
| Q34278987 | Markerless EPID image guided dynamic multi-leaf collimator tracking for lung tumors. |
| Q37472654 | Metabolic tumor volume on FDG-PET/CT is a possible prognostic factor for Stage I lung cancer patients treated with stereotactic body radiation therapy: a retrospective clinical study |
| Q42093083 | Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts. |
| Q40656245 | Multicenter prospective study of sublobar resection for c-stage I non-small cell lung cancer patients unable to undergo lobectomy (KLSG-0801): complete republication |
| Q46051924 | NTCP modelling of lung toxicity after SBRT comparing the universal survival curve and the linear quadratic model for fractionation correction |
| Q36807138 | New developments in radiation therapy for head and neck cancer: intensity-modulated radiation therapy and hypoxia targeting |
| Q33758565 | No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236 |
| Q34167597 | Non-surgical management of stage I lung cancer |
| Q47144992 | Off-target-isocentric approach in non-coplanar Volumetric Modulated Arc Therapy (VMAT) planning for lung SBRT treatments |
| Q42110893 | On the use of hyperpolarized helium MRI for conformal avoidance lung radiotherapy. |
| Q37993783 | Optimal radiotherapy for non-small-cell lung cancer: current progress and future challenges |
| Q59587525 | Outcomes of stereotactic radiotherapy for a new clinical stage I lung cancer arising postpneumonectomy |
| Q36476212 | Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective study |
| Q33627751 | Phase I study of accelerated conformal radiotherapy for stage I non-small-cell lung cancer in patients with pulmonary dysfunction: CALGB 39904. |
| Q64277127 | Phase II study of compensator-based non-coplanar intensity-modulated radiotherapy for Stage I non-small-cell lung cancer |
| Q42246538 | Positioning accuracy for lung stereotactic body radiotherapy patients determined by on-treatment cone-beam CT imaging |
| Q37739358 | Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors |
| Q36524133 | Prognostic factors for local control of stage I non-small cell lung cancer in stereotactic radiotherapy: a retrospective analysis |
| Q89996520 | Prognostic impact of solid tumor component diameter in early-stage non-small cell lung carcinoma treated with intensity-modulated fractionated radiotherapy: a retrospective analysis impact of solid tumor component diameter in NSCLC treated with IMRT |
| Q50050183 | Proton therapy for non-small cell lung cancer: Current evidence and future directions |
| Q38256158 | Radiation pneumonitis after stereotactic radiation therapy for lung cancer |
| Q46419590 | Radiation safety issues with positron-emission/computed tomography simulation for stereotactic body radiation therapy |
| Q55111360 | Radiation safety issues with positron‐emission/computed tomography simulation for stereotactic body radiation therapy. |
| Q95841272 | Radiation-Induced Secondary Cancer Risk Assessment in Patients With Lung Cancer After Stereotactic Body Radiotherapy Using the CyberKnife M6 System With Lung-Optimized Treatment |
| Q36326883 | Radical stereotactic radiosurgery with real-time tumor motion tracking in the treatment of small peripheral lung tumors |
| Q36363955 | Radiobiological modeling analysis of the optimal fraction scheme in patients with peripheral non-small cell lung cancer undergoing stereotactic body radiotherapy |
| Q37458027 | Radiobiological modeling of two stereotactic body radiotherapy schedules in patients with stage I peripheral non-small cell lung cancer |
| Q33787072 | Radiofrequency ablation for early-stage nonsmall cell lung cancer |
| Q102379416 | Radiomic prediction of radiation pneumonitis on pretreatment planning computed tomography images prior to lung cancer stereotactic body radiation therapy |
| Q57875955 | Radiothérapie en conditions stéréotaxiques des patients inopérables |
| Q40010886 | Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study |
| Q35157799 | Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report |
| Q80100945 | Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors |
| Q43255216 | Results of a preliminary study using hypofractionated involved-field radiation therapy and concurrent carboplatin/paclitaxel in the treatment of locally advanced non-small-cell lung cancer |
| Q34580469 | Rib fracture after stereotactic radiotherapy for primary lung cancer: prevalence, degree of clinical symptoms, and risk factors. |
| Q35541222 | Rib fracture after stereotactic radiotherapy on follow-up thin-section computed tomography in 177 primary lung cancer patients |
| Q40179018 | SBRT for lung oligometastases: Who is the perfect candidate? |
| Q35200592 | SBRT in operable early stage lung cancer patients. |
| Q42384628 | SBRT versus lobectomy in stage I NSCLC: knowns, unknowns and its interpretation |
| Q44555068 | Safety and effectiveness of stereotactic body radiotherapy for a clinically diagnosed primary stage I lung cancer without pathological confirmation |
| Q38161371 | Scalpel or SABR for Treatment of Early-Stage Lung Cancer: Clinical Considerations for the Multidisciplinary Team |
| Q46834489 | Small cell lung cancer |
| Q84483109 | Spontaneous pneumothorax after stereotactic radiotherapy for non-small-cell lung cancer |
| Q36780656 | Stage I non-small cell lung cancer: results for surgery in a patterns-of-care study in Sydney and for high-dose concurrent end-phase boost accelerated radiotherapy. |
| Q37902239 | Status of particle therapy for lung cancer |
| Q42079167 | Stereotactic Body Radiation Therapy (SBRT) for Unresectable Pancreatic Carcinoma |
| Q52592765 | Stereotactic Body Radiation Therapy for Pulmonary Oligometastases Arising from Non-lung Primaries in Patients Without Extrapulmonary Disease. |
| Q40932457 | Stereotactic Body Radiotherapy (SBRT) with Lower Doses for Selected Patients with Stage I Non-small-cell Lung Cancer (NSCLC). |
| Q35667866 | Stereotactic ablative radiotherapy for stage I NSCLC: Successes and existing challenges |
| Q37127178 | Stereotactic ablative radiotherapy in the UK: current status and developments |
| Q34667302 | Stereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review |
| Q37348287 | Stereotactic body radiation therapy (SBRT) for lung malignancies: preliminary toxicity results using a flattening filter-free linear accelerator operating at 2400 monitor units per minute. |
| Q37038910 | Stereotactic body radiation therapy for early-stage non-small-cell lung cancer |
| Q34010065 | Stereotactic body radiation therapy for inoperable early stage lung cancer |
| Q60912983 | Stereotactic body radiation therapy for non-small cell lung cancer: A review |
| Q36105945 | Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation |
| Q34368868 | Stereotactic body radiation therapy for stage I non-small cell lung cancer: a small academic hospital experience |
| Q37420376 | Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer |
| Q64096283 | Stereotactic body radiation therapy in early-stage NSCLC: historical review, contemporary evidence and future implications |
| Q37649474 | Stereotactic body radiation therapy: a novel treatment modality |
| Q37123115 | Stereotactic body radiation therapy: transcending the conventional to improve outcomes |
| Q38560967 | Stereotactic body radiotherapy (SBRT) for the treatment of inoperable stage I non-small cell lung cancer patients |
| Q90481023 | Stereotactic body radiotherapy feasibility for patients with peripheral stage I lung cancer and poor pulmonary function |
| Q38155155 | Stereotactic body radiotherapy for early stage lung cancer |
| Q35143839 | Stereotactic body radiotherapy for early-stage non-small cell lung cancer: clinical outcomes from a National Patient Registry |
| Q38059705 | Stereotactic body radiotherapy for metachronous multisite oligo-recurrence: a long-surviving case with sequential oligo-recurrence in four different organs treated using locally radical radiotherapy and a review of the literature |
| Q33813917 | Stereotactic body radiotherapy for very elderly patients (age, greater than or equal to 85 years) with stage I non-small cell lung cancer |
| Q36734816 | Stereotactic body radiotherapy using gated radiotherapy with real-time tumor-tracking for stage I non-small cell lung cancer |
| Q38175120 | Stereotactic body radiotherapy: a critical review for nonradiation oncologists |
| Q28076058 | Stereotactic body radiotherapy: current strategies and future development |
| Q53395105 | Stereotactic radiosurgery for a cardiac sarcoma: a case report. |
| Q44641177 | Stereotactic radiotherapy for lung cancer using a flattening filter free Clinac |
| Q54959548 | Stereotactic radiotherapy for lung cancer using a flattening filter free Clinac. |
| Q26863046 | Surgery in 2013 and beyond |
| Q48369218 | Surgery versus stereotactic body radiation therapy for stage I non-small cell lung cancer: A comprehensive review. |
| Q48906209 | Technical description, phantom accuracy, and clinical feasibility for single-session lung radiosurgery using robotic image-guided real-time respiratory tumor tracking |
| Q34463642 | The CyberKnife radiosurgery system for lung cancer |
| Q89520902 | The PEMBRO-RT phase II randomized trial and the evolution of therapy for metastatic non-small cell lung cancer: a historical perspective |
| Q30443893 | The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy |
| Q34366525 | The impact of abdominal compression on outcome in patients treated with stereotactic body radiotherapy for primary lung cancer |
| Q33655601 | The impact of cine EPID image acquisition frame rate on markerless soft-tissue tracking |
| Q47734152 | The impact of technology on the changing practice of lung SBRT. |
| Q37743289 | The role of stereotactic body radiotherapy in the management of non-small cell lung cancer: an emerging standard for the medically inoperable patient? |
| Q64121433 | Three-dimensional dose comparison of flattening filter (FF) and flattening filter-free (FFF) radiation therapy by using NIPAM gel dosimetry |
| Q36835347 | Toxicity and outcomes of thoracic re-irradiation using stereotactic body radiation therapy (SBRT). |
| Q35050966 | Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer |
| Q37589200 | Treatment advances for medically inoperable non-small-cell lung cancer: emphasis on prospective trials |
| Q26853124 | Treatment of early stage non-small cell lung cancer: surgery or stereotactic ablative radiotherapy? |
| Q37614582 | Treatment options for stage I non-small-cell lung carcinoma patients not suitable for lobectomy |
| Q38930349 | Treatment: Radiation Therapy |
| Q39015830 | Tumor control probability modeling for stereotactic body radiation therapy of early-stage lung cancer using multiple bio-physical models. |
| Q39061401 | Tumor hypoxia and reoxygenation: the yin and yang for radiotherapy |
| Q42148524 | Volumetric modulated arc planning for lung stereotactic body radiotherapy using conventional and unflattened photon beams: a dosimetric comparison with 3D technique |
| Q80737405 | [Progress in radiation therapy and integration in Tenon hospital (AP-HP) of new advances in routine practices of radiotherapy for non-small-cell lung cancer] |
| Q55441727 | [Radiation pneumonitis after stereotactic body radiation therapy for early stage non-small cell lung cancer]. |
| Q53288899 | [Stereotactic body radiaton therapy for 15 patients with small lung neoplasms]. |